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Stem Cell DeficiencyERIC H. CHAN, LUXIA CHEN, JIAN YU RAO, FEI YU, AND SOPHIE X. DENG PURPOSE: To investigate changes in limbal basal
epithelial cell density in eyes with limbal stem cell defi-
ciency (LSCD) using in vivo confocal laser scanning mi-
croscopy.
 DESIGN: Retrospective observational comparative
study.
 METHODS: A total of 43 eyes of 30 patients diagnosed
with LSCD were included in the study. Ten eyes from
normal subjects were included as control. Confocal imag-
ing of the central cornea, and the superior, nasal, inferior
and temporal limbus were collected using the Heidelberg
Retina Tomograph III Rostock Corneal Module. Basal
cell density in all locations was measured by 2 indepen-
dent observers.
 RESULTS: The mean basal cell density of the normal
group was 9264 ± 598 cells/mm2 in the cornea and
7120 ± 362 cells/mm2 in the limbus. In the LSCD group,
the mean basal cell density in the cornea decreased 31.0%
(6389 ± 1820 cells/mm2, P< .001) and in the limbus
decreased 23.6% (5440 ± 1123 cells/mm2, P< .001)
compared to that in the control. There was a trend of basal
cell density decline in more advanced stages of LSCD.
The basal cell density declined in the unaffected regions
at a similar degree as that in the affected region in sectoral
LSCD (P> .05). The basal cell diameter increased by
24.6% in the cornea (14.7 mm) and by 15.7% in the
limbus (15.5 mm) compared to the control.
 CONCLUSIONS: Basal cell density in both central
cornea and limbus decreases in LSCD. Limbal stem cells
(LSCs) are affected globally and basal cell density could
be used as a parameter to measure LSC function at the
early stages of the disease process. (Am J Ophthalmol
2015;160(4):678–684. Published by Elsevier Inc. This
is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).)upplemental Material available at AJO.com.
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IMBAL STEM CELLS (LSCS) ARE RESPONSIBLE FOR THE
normal homeostasis and wound repair of the corneal
epithelium. When there is an insufficient number of
functional stem cells, a normal transparent corneal epithe-
lial surface cannot be maintained and the eventual result
is limbal stem cell deficiency (LSCD).1,2 There are
multiple etiologies of LSCD, and the hallmark is invasion
of the conjunctival epithelium on the cornea. Etiologies of
LSCD include multiple surgeries, Stevens-Johnson syn-
drome, chemical injury, chronic contact lens wear, aniridia,
and chronic keratitis. Common signs of LSCD are opacity
and irregularity of epithelium, recurrent epithelial defects,
and neovascularization. Common symptoms include photo-
phobia, pain, redness, tearing, and decreased vision.3,4
The limbus harbors LSCs, and the palisades of Vogt are
thought to be a site of the LSC niche.5,6 Damage to the
stem cell niche and its population impairs long-term regen-
eration of corneal epithelial cells, although acute injury to
the cornea epithelium may be healed in the short term by
existing corneal transient amplifying cells.7,8 Damage to
the limbus also leads to the loss of the barrier that
prevents invasion of the conjunctiva onto the ocular
surface.9 Conjunctivalization of the corneal surface leads
to significant visual loss and eventually to blindness.
The diagnosis of LSCD is mostly based on clinical presen-
tation. Persistent epithelial defect due to impaired epithelial
wound healing that resulted from an insufficient number of
functional LSCs is one common presentation. Stippled fluo-
rescein staining in a vortex pattern and late fluorescein
staining are indicative of abnormal corneal epithelium or
conjunctival epithelium, which are typical early signs of
LSCD. However, these clinical signs are often subtle and
are not pathognomonic. Impression cytology can detect
the presence of conjunctival goblet cells on the corneal sur-
face and thus confirms the diagnosis of LSCD.10 However,
goblet cells might be absent from some patients with chem-
ical burns, Stevens-Johnson syndrome, or topical medica-
tion toxicity from long-term glaucoma medications.11–13
Sensitivity of impression cytology is also low. A negative
result does not necessary rule out LSCD.
In vivo laser scanning confocal microscopy has been
used to understand the microstructural changes in normal
and pathologic conditions including various epithelial
diseases, and to investigate quantifiable parameters, such
as density and size.14 On the basis of previous work, corneal
basal cell density and subbasal nerve density were identified
as potential parameters for the diagnosis of LSCD and for0002-9394/$36.00
http://dx.doi.org/10.1016/j.ajo.2015.06.026
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the characterization of the severity of LSCD.15 In the cur-
rent study, we investigated whether limbal basal cell den-
sity is another parameter in assessing LSCD.METHODS
THIS OBSERVATIONAL, CROSS-SECTIONAL COMPARATIVE
study was approved by the Institutional Review Board at
the University of California, Los Angeles. Each patient un-
derwent a comprehensive eye examination, slit-lamp mi-
croscopy, and in vivo laser scanning confocal microscopy.
Twenty-five eyes also underwent impression cytology after
in vivo confocal microscopy. Ten eyes of normal subjects
without ocular pathology by slit-lamp examination and
without previous history of ocular disease were selected as
the control group.
Based on the results of the slit-lamp examination and
fluorescein staining, we characterized LSCD in the 43
affected eyes as early, intermediate, or late stage according
to the criteria previously reported.15 Briefly, the early
stage was characterized by stippling or late fluorescein
staining; the intermediate stage was characterized by
persistent, late fluorescein staining in a vortex pattern;
and the late stage was characterized by the same vortex
pattern of staining and a history of cornea epithelial
defect or persistent epithelial defect. Representative slit-
lamp photographs are shown in Figure 1. Affected limbal
and corneal areas were identified by the location of fluo-
rescein staining observed during slit-lamp examination.
Affected areas were then stratified into superior, nasal,
inferior, and temporal limbal sections. Unaffected areas
were determined as the limbal sections outside of the
affected regions. Each patient’s chart was also reviewed
to determine any underlying etiology and predisposing
factors that led to LSCD.
 CONFOCAL MICROSCOPY ANALYSIS: Confocal images
were taken by theHeidelbergRetina Tomograph III Rostock
Corneal Module Confocal Microscope (Heidelberg Engi-
neering GmBH, Dossenheim, Germany). A minimum of 3
scans of the central cornea and of the superior, nasal, infe-
rior, and temporal limbus were collected. A minimum of 3
image frames of the corneal or limbal basal cell layer at
each location were selected if the images clearly showed
cellular morphology. Each image frame was 400 3
400 mm. Two independent, masked observers then
proceeded to measure basal cell density in all 3 images as
recommended by the manufacturer and as previously re-
ported.15 Cell size was calculated by dividing the size of
the area by the number of cells within this area. The average
cell diameter was then derived from the calculated cell area.
 STATISTICAL ANALYSIS: Statistical analyses were
performed using SAS software version 9.4 (SAS, Inc,VOL. 160, NO. 4 BASAL CELL DENSITY REDUCES INCary, North Carolina, USA). Intraclass correlation coef-
ficients were used to assess the reliability of density
measurements obtained by 2 independent observers.
Kruskal-Wallis tests and 2-tailed t tests were used for anal-
ysis when appropriate. Any P value less than .05 was
considered to indicate statistical significance.RESULTS
FORTY-THREE EYES OF 30 PATIENTS DIAGNOSED WITH LSCD
from 2010 to 2014 were included in this study. Of those
30 patients with LSCD (Supplemental Table 1, available
at AJO.com), the mean age was 59.3 years (range, 24–94
years) for the LSCD group and 46.3 years (range, 27–88
years) for the control group (P ¼ .14). Twenty-two eyes
in the LSCD group were of female patients and 21 were
of male patients (P ¼ .38). The diagnosis of LSCD was
confirmed in 11 eyes by impression cytology. The overall
leading etiologies of LSCD were contact lens wear
(32.6%) and multiple surgeries (27.9%).
Two independent observers performed the basal cell den-
sity measurements in a masked fashion. There was high
agreement between the observers, with an intraclass correla-
tion coefficient of 0.977 (Supplemental Figure, available at
AJO.com). The mean basal cell density of the normal con-
trol group was 92646 598 cells/mm2 in the cornea and 7120
6 362 cells/mm2 in the limbus. The highest density was in
the superior limbus (74586 355 cells/mm2), and lower den-
sities were observed in the temporal limbus (7434 6 653
cells/mm2), the inferior limbus (7042 6 775 cells/mm2),
and the nasal limbus (6782 6 582 cells/mm2). The mean
basal cell density of the nasal limbus differed significantly
from that of the superior limbus (P¼ .031) and the temporal
limbus (P ¼ .039). All other pairwise comparisons between
limbal regions did not reveal significant differences
(Supplemental Table 2, available at AJO.com).
The mean basal cell density of the cornea (63896 1820
cells/mm2) was 31.0% lower in the LSCD group than in the
control group (P < .001; Figure 2). In addition, the mean
basal cell density of all 4 limbal regions (5440 6 1123
cells/mm2) was 23.6% lower in the LSCD group than in
the control group (P < .001; Figure 2). Because contact
lens wear was the leading cause of LSCD in our series, we
compared basal cell density in contact lens wearers and
non–contact lens wearers. There was no significant differ-
ence between the 2 groups in corneal basal cell density
(6818 6 1668 cells/mm2 and 6068 6 1845 cells/mm2,
respectively; P ¼ .22) or limbal basal cell density (5386
6 690 cells/mm2 and 53506 1299 cells/mm2, respectively;
P¼ .69). This result indicates that the decrease in basal cell
density is a general phenomenon in LSCD and is not
limited to the contact lens etiology.
When the mean basal cell density of different stages of
LSCD were compared, there was a trend toward a decrease679LIMBAL STEM CELL DEFICIENCY
FIGURE 1. Representative slit-lamp photographs (Left column) and fluorescein staining patterns (Middle left column) of normal
controls and of patients with early-, intermediate-, and late-stage limbal stem cell deficiency are shown. Representative in vivo
confocal images of the corneal (Middle right column) and limbal (Right column) basal epithelium in normal controls and in patients
with limbal stem cell deficiency are shown.in basal cell density in the cornea and limbal regions in
more advanced disease. The mean basal cell density of
the cornea was lower by 23.5% in the early stage, 35.6%
in the intermediate stage, and 56.2% in the late stage.
The differences in corneal basal cell density between
respective stages were significant (for each comparison, P
< .05). Compared with the mean basal cell density of all
limbal regions in control subjects, the mean basal cell den-
sity of all 4 limbal regions of patients with LSCDwas 20.5%
lower in the early stage, 25.3% lower in the intermediate
stage, and 31.7% lower in the late stage (Figure 1). No sig-
nificant differences in the mean limbal basal cell density
were found among different stages.
Significant decreases in densities were observed in all 4
limbal regions with LSCD when compared with those in
the respective region in normal eyes (all P < .05,
Figure 3). Additionally, we examined the basal cell density
in limbal regions that appeared clinically unaffected by
LSCD (Supplemental Table 3, available at AJO.com).
The mean basal cell density was also significantly decreased
in the unaffected regions at a similar degree as in the
affected regions (for each comparison, P < .05; Figure 4).680 AMERICAN JOURNAL OFThe cell borders became indistinguishable in many of the
eyes with late-stage LSCD; therefore, it was not feasible
to reliably determine the cell density.
When cell density was converted to cell size, the mean
cell diameters of the normal control group were 11.8 mm
in the cornea and 13.4 mm in the limbus (Supplemental
Table 4, available at AJO.com). The cell diameter of the
corneal and limbal basal cells increased in more advanced
stages (Figure 5).DISCUSSION
USE OF IN VIVO LASER SCANNING MICROSCOPY HAS
increased in the diagnosis of infectious keratitis, corneal
dystrophies, and recently LSCD. Previous reports have
described cellular changes in different stages of LSCD.15–17
In the current study, we have expanded the investigation
of basal cell density in limbal regions. All measurements
were obtained in a masked fashion by 2 independent
observers. A very high intraclass correlation (0.977) of theOCTOBER 2015OPHTHALMOLOGY
FIGURE 2. Box-whisker plots of the basal cell density of the central cornea (Top left) and the average of all 4 limbal regions (Top
right). The relative basal cell density (%; limbal stem cell deficiency vs normal control) in patients with limbal stem cell deficiency in
relation to that of normal control subjects is shown for the cornea (Bottom left) and all limbal regions (Bottom right). LSCD, limbal
stem cell deficiency. Each asterisk denotes P< .05.measurements indicates that the potential for variation is
low. In addition, the average cell diameter in the control
obtained in our study, 11.8 mm, is within the reported
range of 10–12 mm,18–21 and the basal cell density of the
limbus in our normal control is also comparable to those
previously published.21 These findings further validate our
method used in the current study.
This larger study confirms our previous findings that basal
cell density in the central cornea decreases significantly in
eyes with LSCD and that the degree of reduction positively
correlates with the severity of the disease. Basal cell density
was also found to decrease significantly in the limbus in eyes
with LSCD. A significant decrease (8.9%) in limbal basal
cell density in an older age group (age >45 years) has
been reported.21 The decrease in our LSCD group was
more than 20.5% and the average ages of subjects in our con-
trol group and LSCD group were similar. Therefore, we
believe that this large reduction of basal cell density in the
limbus of patients with LSCD was not due to age but due
to the pathology of LSCD. This reduction was not limited
to contact lens–wearing subjects, but was rather a general
phenomenon seen in all other etiologies of LSCD.
Congenital aniridia–induced LSCD has been studied
with in vivo confocal microscopy, and findings of suchVOL. 160, NO. 4 BASAL CELL DENSITY REDUCES INstudies have typically been similar to those seen in LSCD
in general.16,17 In particular, basal cell density in patients
with severe aniridia-related keratopathy was significantly
reduced and comparable in value to the basal cell density
in patients with late-stage disease in our study. Based on
basal cell density alone, it appears that in later stages of
aniridia-related keratopathy, the damage to the limbus
may be as much as or more than that due to other etiologies
of LSCD. It is also possible that owing to loss of cell borders
in the late stage of LSCD, we were unable to obtain a reli-
able cell count. This has led to a sampling bias in the
advanced stage of LSCD toward a higher basal cell density.
Although in vivo confocal microscopy has yet to defini-
tively distinguish LSCs, cellular characteristics such as a
high nuclear-to-cytoplasmic ratio and small cell size have
been suggested. Limbal crypts within the regions of the
palisades of Vogt and deep limbal stroma are regions where
LSCs are proposed to locate.6,22–24 These limbal crypt
structures are found to be predominantly in the superior
and inferior limbus. Injury to these regions may exert a
more detrimental effect on the LSCs. In addition, a
decrease in basal cell density corresponds to a general
increase in basal cell size in eyes with LSCD
(Supplemental Table 3, available at AJO.com). This result681LIMBAL STEM CELL DEFICIENCY
FIGURE 3. Box-whisker plots of the limbal basal cell density in each of 4 limbal regions: inferior (Top left), nasal (Top right),
superior (Bottom left), and temporal limbus (Bottom right). LSCD, limbal stem cell deficiency. Each asterisk denotes P< .05.suggests that there was a loss of the smaller cell population
in the limbus that are presumed to be LSCs, given their
expression pattern, and have been found to have greater
proliferative potential in vitro.25 When there are insuffi-
cient LSCs, there might be more stress on the remaining
stem cells to proliferate beyond their capacity. This stress
in turn could further deplete the remaining stem cell pop-
ulation. These larger cells could represent differentiated
cells, which express different cell surface markers and
possibly influence cell-cell interactions.26 Additionally,
these larger cells have limited regenerative potential.
A significant reduction in basal cell density was already
seen in the early stage of LSCD in both the cornea (23.5%)
and the limbus (20.5%), and basal cell density was further
decreased in intermediate stage. Therefore, basal cell density
reduction in the cornea and limbus is likely to be an early sign
of LSCD. These findings also suggest LSCD to be much more
insidious, with widespread progression that cannot be
observed clinically at the early stage. In addition, the cellular
changes may occur as a global phenomenon and precede the
clinical presentation in LSCD. Invasion of conjunctival
epithelial cells onto the cornea is likely a late-stage finding,
and this explains the low yield of positive impression cytology
results in the early stage of LSC dysfunction/deficiency. This682 AMERICAN JOURNAL OFhypothesis is also supported by a surprising finding from the
current study that the degree of basal cell density reduction
was similar in the clinically affected and unaffected limbal
regions in eyes with sectoral LSCD. Therefore, basal cell
density could be one parameter to assess the population and
function of LSCs. Identification of such early dysfunction of
LSCs can be used to guide treatment and prevent further
damage. The cornea has the ability to repair itself in the short
term by using its remaining transient amplifying cells.7 Signs
of dysfunction of the limbus may be best detected by in vivo
laser scanning confocal microscopy.
Accurate staging of LSCD is important in monitoring
disease progression and treatment outcome. Transplanta-
tion of autologous stem cells has been shown to cure
LSCD.27 However, quantitative criteria for identification
of candidates for transplantation are lacking. Parameters
such as corneal and limbal basal cell density and subbasal
nerve density could be used to classify the degree of
LSCD. Seeing firsthand the health of the epithelial tissue
at a cellular level can provide a better evaluation of the
viability of the graft and the recovery of normal corneal
epithelium.28
There are limitations to this study. Assessment of epithe-
lial cell density requires discernible cells visualized onOCTOBER 2015OPHTHALMOLOGY
FIGURE 4. Box-whisker plots of the limbal basal cell density of the clinically affected and unaffected regions in the inferior (Top
left), nasal (Top right), superior (Bottom left), and temporal limbus (Bottom right). Each asterisk denotes P< .05.
FIGURE 5. Relative basal cell diameter (%; limbal stem cell deficiency vs normal control) is shown for the central cornea (Left) and
total limbus (Right).image frames. Loss of clear cellular borders, cell clumping,
and fibrosis in advanced disease limited the measurement of
cell density and perhaps led to some bias toward the
selection of only those regions that were less severely
affected to obtain cell counts in the intermediate and
late stages. Patients with late-stage LSCD were commonly
found to have corneal and limbal epithelium replaced by
conjunctival cells accompanied by stromal scarring andVOL. 160, NO. 4 BASAL CELL DENSITY REDUCES INinfiltration of inflammatory cells. Thus, limbal basal cell
density often could not be obtained in late-stage disease
because very few basal cells could be identified. Because
of such selection bias in the more advanced stage of
LSCD, the actual basal cell density in more severe LSCD
is probably much lower than the values we obtained. The
assessment of basal cell density in such a late stage might
better rely on the characteristics of cell morphology.29683LIMBAL STEM CELL DEFICIENCY
In summary, basal cell density in the limbus significantly
decreases in LSCD, and basal cell density could serve as one684 AMERICAN JOURNAL OFof the parameters to measure LSC function, particularly in
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SUPPLEMENTAL FIGURE. Correlation plot of measured
corneal and limbal basal cell densities for both observers. Intra-
class correlation coefficient of 0.977 indicates high reliability
between measurements made by the 2 observers.
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SUPPLEMENTAL TABLE 1. Diagnosis and Etiology of Limbal Stem Cell Deficiency
Eye # Age Sex Diagnosis/Etiology Eye Clinical Stage Clinical Findings
1 48 M SJS, DES OD Early Mild superior stippling staining
2 86 F DES OD Early Mild superior stippling staining
3 85 F Multiple surgeries OS Early Superior stippling staining
4 44 M SJS, DES OD Early Diffuse punctate keratopathy, inferior pannus
5 78 M Multiple surgeries OD Early Moderate superficial NV, moderate stippling staining
6 94 M Drug toxicity OS Early Mild stippling staining
7 36 F CL OD Early Late fluorescein staining
8 59 F Multiple surgeries OS Early Superior stippling staining
9 63 M Multiple surgeries OD Early Inferior vortex keratopathy
10 28 F CL OS Early Mild inferior punctate staining
11 34 M SJS, DES OS Early Mild inferior punctate staining
12 54 F CL OD Early Superior vortex keratopathy
13 82 M Chronic keratoconjunctivitis OS Early Superior vortex keratopathy
14 24 M Chemical injury OS Early Mild punctate staining
15 55 F CL OD Early Inferior stippling staining, inferior pannus
16 55 F CL OD Early Superior epithelial irregularity
17 51 F CL OS Early Superior epithelial irregularity
18 51 F CL OD Early Mild inferior punctate staining
19 36 F CL OS Early Mild stippling staining
20 60 M Multiple surgeries OD Intermediate Superior vortex keratopathy
21 77 F Multiple surgeries OD Intermediate Vortex keratopathy
22 55 M Multiple surgeries OD Intermediate Vortex keratopathy
23 92 M Idiopathic OS Intermediate Superior vortex keratopathy
24 78 M Multiple surgeries OD Intermediate Vortex keratopathy
25 94 M Drug toxicity OD Intermediate Superior vortex keratopathy
26 56 F CL OS Intermediate Vortex keratopathy
27 63 M Multiple surgeries OD Intermediate Vortex keratopathy
28 28 F CL OD Intermediate Superior-nasal vortex keratopathy, epithelial defect
29 37 M Chronic keratoconjunctivitis OD Intermediate Vortex keratopathy, epithelial defect
30 37 M Chronic keratoconjunctivitis OD Intermediate Inferior vortex keratopathy
31 49 M DES, multiple surgeries OS Intermediate Vortex keratopathy
32 46 F CL OD Intermediate Superior limbus conjunctivization
33 46 F CL OS Intermediate Vortex keratopathy, inferior punctate keratopathy
34 83 F Drug toxicity, DES OD Intermediate Superior punctate keratopathy
35 54 F CL OS Intermediate Vortex keratopathy
36 62 M Multiple surgeries, drug toxicity OD Intermediate Superior-temporal vortex keratopathy
37 82 M Multiple surgeries, drug toxicity OS Intermediate Vortex keratopathy
38 40 F CL OD Intermediate Superior stippling staining, vortex keratopathy
39 76 F DES, infectious keratitis OS Intermediate Superior vortex keratopathy
40 86 F DES OD Intermediate Diffuse vortex keratopathy
41 48 M SJS, DES OS Late Diffuse subepithelial haze, diffuse stippling staining
42 58 F Chemical injury, multiple surgeries OS Late Complete conjunctivilization
43 79 M Infectious keratitis OS Late Epithelial defect, diffuse pannus
CL ¼ contact lens; DES ¼ dry eye syndrome; SJS ¼ Stevens-Johnson syndrome; NV ¼ neovascularization.
VOL. 160, NO. 4 684.e3BASAL CELL DENSITY REDUCES IN LIMBAL STEM CELL DEFICIENCY
SUPPLEMENTAL TABLE 2. Corneal and Limbal Basal Cell Density in the Control and Limbal Stem Cell Deficiency Groups
Control (Mean 6 SD Cells/mm2) All Stages of LSCD Early Stage Intermediate Stage Late Stage
Central cornea 9264 6 598 6389 6 1820* 7090 6 1516* 5964 6 1834* 4060 6 1137*
All limbal regions 7120 6 362 5440 6 1123* 5662 6 904* 5321 6 1214* 4863 6 1497*
Superior limbus 7458 6 355 5299 6 1262* 5646 6 913* 5041 6 1363* 4859 6 1926*
Inferior limbus 7042 6 775 5683 6 1408* 5844 6 1411* 5476 6 1447* 6318 6 653*
Nasal limbus 6782 6 582 5761 6 1419* 6085 6 1029* 5605 6 1583* 5455 6 1198
Temporal limbus 7434 6 653 5628 6 1048* 5988 6 925* 5443 6 1126* 5123 6 436*
LSCD ¼ limbal stem cell deficiency.
*Denotes P < .05.
SUPPLEMENTAL TABLE 3. Corneal and Limbal Basal Cell Density in the Affected and Unaffected Limbal Regions
Early Stage (Mean 6 SD Cells/mm2) Intermediate Stage Late Stage
A U A U A U
Superior limbus 5617 6 1082* 5695 6 551* 5190 6 1451* 4346 6 402* 5206 6 2450* 4279 6 405*
Inferior limbus 5651 6 1328* 6139 6 1522 5068 6 1617* 5642 6 1360* 6054 6 428* 6583 6 820
Nasal limbus 5812 6 855* 6221 6 1102 4386 6 1900* 6054 6 1190* 5455 6 1198 N/Aa
Temporal limbus 5886 6 952* 6032 6 933* 5767 6 968* 5314 6 1173* 5333 6 201* 4913 6 550*
A ¼ affected; U ¼ unaffected.
*Denotes P < .05.
aN/A denotes no eyes were measured.
SUPPLEMENTAL TABLE 4. Corneal and Limbal Basal Cell
Diameter in the Control and Limbal Stem Cell Deficiency
Groups
Control (mm)
All Stages
of LSCD
Early
Stage
Intermediate
Stage
Late
Stage
Central cornea 11.8 14.7 13.7 15.3 18.1
All limbal regions 13.4 15.5 15.0 15.9 15.8
Superior limbus 13.0 15.9 15.2 16.4 17.2
Inferior limbus 13.5 15.4 15.1 15.7 14.2
Nasal limbus 13.7 15.4 14.6 15.8 15.4
Temporal limbus 13.2 15.3 14.7 15.6 15.8
LSCD ¼ limbal stem cell deficiency.
684.e4 OCTOBER 2015AMERICAN JOURNAL OF OPHTHALMOLOGY
